Amundi Index Solutions - Amundi Prime Europe UCITS ETF DR (GBP) | PRIERegister to Unlock Ratings |
Performance History | 30/09/2024 |
Growth of 1,000 (GBP) | Advanced Graph |
Fund | -3.5 | 25.8 | -9.5 | 16.2 | 7.6 | |
+/-Cat | -7.8 | 10.4 | -1.2 | 4.7 | 1.8 | |
+/-B’mrk | -6.0 | 8.1 | -5.0 | 3.0 | 0.2 | |
Category: Europe Large-Cap Blend Equity | ||||||
Category Benchmark: Morningstar DM Eur TME NR EUR |
Key Stats | ||
Closing Price 30/10/2024 | GBX 2449.25 | |
Day Change | -0.76% | |
Morningstar Category™ | Europe Large-Cap Blend Equity | |
Volume | 154 | |
Exchange | LONDON STOCK EXCHANGE, THE | |
ISIN | LU1931974262 | |
Fund Size (Mil) 29/10/2024 | EUR 119.78 | |
Share Class Size (Mil) 29/10/2024 | EUR 63.11 | |
Ongoing Charge 10/11/2023 | 0.05% |
Investment Objective: Amundi Index Solutions - Amundi Prime Europe UCITS ETF DR (GBP) | PRIE |
To track the performance of Solactive GBS Developed Markets Europe Large & Mid Cap EUR Index (the "Index"), and to minimize the tracking error between the net asset value of the sub-fund and the performance of the Index. |
Returns | ||||||||||||||||
|
Management | ||
Manager Name Start Date | ||
- - | ||
Inception Date 30/01/2019 |
Advertisement |
Category Benchmark | |
Fund Benchmark | Morningstar Benchmark |
Solactive GBS DM Euro L&M Cap NR EUR | Morningstar DM Eur TME NR EUR |
Target Market | ||||||||||||||||||||
|
Portfolio Profile for Amundi Index Solutions - Amundi Prime Europe UCITS ETF DR (GBP) | PRIE | 28/10/2024 |
|
|
Top 5 Holdings | Sector | % |
Novo Nordisk AS Class B | Healthcare | 3.28 |
ASML Holding NV | Technology | 2.61 |
Nestle SA | Consumer Defensive | 2.41 |
SAP SE | Technology | 2.30 |
AstraZeneca PLC | Healthcare | 2.10 |
Increase Decrease New since last portfolio | ||
Amundi Index Solutions - Amundi Prime Europe UCITS ETF DR (GBP) | PRIE |